Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
American Journal of Epidemiology
|
May 30, 2002
Lower limb venous insufficiency and tobacco smoking: a case-control study
Sophie Gourgou, Florence Dedieu, Hélène Sancho-Garnier
Addiction (Abingdon, England)
|
September 28, 2005
A randomized trial assessing the Five-Day Plan for smoking cessation
Raymond Romand, Sophie Gourgou, Hélène Sancho-Garnier
Frontiers in Oncology
|
April 21, 2018
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
David Azria, Muriel Brengues, Sophie Gourgou, et al.
Plos One
|
September 21, 2017
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, et al.
Cancers
|
October 14, 2023
Time-Dependent ROC Curve Analysis for Assessing the Capability of Radiation-Induced CD8 T-Lymphocyte Apoptosis to Predict Late Toxicities after Adjuvant Radiotherapy of Breast Cancer Patients
Célia Touraine, Audrey Winter, Florence Castan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Survival end point reporting in randomized cancer clinical trials: a review of major journals
Simone Mathoulin-Pelissier, Sophie Gourgou-Bourgade, Franck Bonnetain, et al.
BMC Cancer
|
December 22, 2022
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, et al.
BMJ Open
|
August 17, 2025
GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancer
Fabienne Portales, Sophie Gourgou, Catherine Fiess, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 24, 2021
Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials
Benjamin Cuer, Thierry Conroy, Beata Juzyna, et al.
Frontiers in Oncology
|
February 2, 2023
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
Jessica Prunaretty, Celine Bourgier, Sophie Gourgou, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
American Journal of Epidemiology
|
May 30, 2002
Lower limb venous insufficiency and tobacco smoking: a case-control study
Sophie Gourgou, Florence Dedieu, Hélène Sancho-Garnier
Addiction (Abingdon, England)
|
September 28, 2005
A randomized trial assessing the Five-Day Plan for smoking cessation
Raymond Romand, Sophie Gourgou, Hélène Sancho-Garnier
Frontiers in Oncology
|
April 21, 2018
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
David Azria, Muriel Brengues, Sophie Gourgou, et al.
Plos One
|
September 21, 2017
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, et al.
Cancers
|
October 14, 2023
Time-Dependent ROC Curve Analysis for Assessing the Capability of Radiation-Induced CD8 T-Lymphocyte Apoptosis to Predict Late Toxicities after Adjuvant Radiotherapy of Breast Cancer Patients
Célia Touraine, Audrey Winter, Florence Castan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Survival end point reporting in randomized cancer clinical trials: a review of major journals
Simone Mathoulin-Pelissier, Sophie Gourgou-Bourgade, Franck Bonnetain, et al.
BMC Cancer
|
December 22, 2022
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, et al.
BMJ Open
|
August 17, 2025
GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancer
Fabienne Portales, Sophie Gourgou, Catherine Fiess, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
November 24, 2021
Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials
Benjamin Cuer, Thierry Conroy, Beata Juzyna, et al.
Frontiers in Oncology
|
February 2, 2023
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
Jessica Prunaretty, Celine Bourgier, Sophie Gourgou, et al.
Page
of 12